1. Academic Validation
  2. The Crystal Structure of Orthocetamol Solved by 3D Electron Diffraction

The Crystal Structure of Orthocetamol Solved by 3D Electron Diffraction

  • Angew Chem Int Ed Engl. 2019 Aug 5;58(32):10919-10922. doi: 10.1002/anie.201904564.
Iryna Andrusenko 1 Victoria Hamilton 2 3 Enrico Mugnaioli 1 Arianna Lanza 1 Charlie Hall 2 4 Jason Potticary 2 Simon R Hall 2 Mauro Gemmi 1
Affiliations

Affiliations

  • 1 Center for Nanotechnology Innovation@NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro 12, Pisa, Italy.
  • 2 Complex Functional Materials Group, School of Chemistry, University of Bristol, Bristol, BS8 1TS, UK.
  • 3 Bristol Centre for Functional Nanomaterials, Centre for Nanoscience and Quantum Information, Tyndall Avenue, Bristol, BS8 1FD, UK.
  • 4 Centre for Doctoral Training in Condensed Matter Physics, HH Wills Physics Laboratory, Tyndall Avenue, Bristol, BS8 1TL, UK.
Abstract

Orthocetamol is a regioisomer of the well-known pain medication paracetamol and a promising analgesic and an anti-arthritic medicament itself. However, orthocetamol cannot be grown as single crystals suitable for X-ray diffraction, so its crystal structure has remained a mystery for more than a century. Here, we report the ab-initio structure determination of orthocetamol obtained by 3D electron diffraction, combining a low-dose acquisition method and a dedicated single-electron detector for recording the diffracted intensities. The structure is monoclinic, with a pseudo-tetragonal cell that favors multiple twinning on a scale of a few tens of nanometers. The successful application of 3D electron diffraction to orthocetamol introduces a new gold standard of total structure solution in all cases where X-ray diffraction and electron-microscope imaging methods fail.

Keywords

3D electron diffraction; nanomaterials; pharmaceutical compound; structure determination; twinning.

Figures
Products